EQT to acquire pharmaceutical services firm Certara

(Reuters) – Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *